These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 24751921)
21. Innate IFN-lambda responses to dsRNA in the human infant airway epithelium and clinical regulatory factors during viral respiratory infections in early life. Salka K; Arroyo M; Chorvinsky E; Abutaleb K; Perez GF; Wolf S; Xuchen X; Weinstock J; Gutierrez MJ; Pérez-Losada M; Pillai DK; Nino G Clin Exp Allergy; 2020 Sep; 50(9):1044-1054. PubMed ID: 32623773 [TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. Ioannidis I; Ye F; McNally B; Willette M; Flaño E J Virol; 2013 Mar; 87(6):3261-70. PubMed ID: 23302870 [TBL] [Abstract][Full Text] [Related]
23. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces. Stanifer ML; Guo C; Doldan P; Boulant S Front Immunol; 2020; 11():608645. PubMed ID: 33362795 [TBL] [Abstract][Full Text] [Related]
24. Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation. Eberle KC; McGill JL; Reinhardt TA; Sacco RE J Virol; 2015 Dec; 90(6):2948-58. PubMed ID: 26719274 [TBL] [Abstract][Full Text] [Related]
25. Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections. Mahlakõiv T; Hernandez P; Gronke K; Diefenbach A; Staeheli P PLoS Pathog; 2015 Apr; 11(4):e1004782. PubMed ID: 25849543 [TBL] [Abstract][Full Text] [Related]
26. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection. Zhang S; Kodys K; Li K; Szabo G Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201 [TBL] [Abstract][Full Text] [Related]
27. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910 [TBL] [Abstract][Full Text] [Related]
28. Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection. Wei H; Wang S; Chen Q; Chen Y; Chi X; Zhang L; Huang S; Gao GF; Chen JL PLoS Pathog; 2014 Jan; 10(1):e1003845. PubMed ID: 24391501 [TBL] [Abstract][Full Text] [Related]
29. Type III Interferon Restriction by Porcine Epidemic Diarrhea Virus and the Role of Viral Protein nsp1 in IRF1 Signaling. Zhang Q; Ke H; Blikslager A; Fujita T; Yoo D J Virol; 2018 Feb; 92(4):. PubMed ID: 29187542 [TBL] [Abstract][Full Text] [Related]
30. Type III Interferons in Viral Infection and Antiviral Immunity. Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714 [TBL] [Abstract][Full Text] [Related]
31. Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production. Xue M; Wang W; He H; Li L; Zhang X; Shi H; Liu P; Feng L J Virol; 2022 Dec; 96(24):e0138822. PubMed ID: 36448799 [TBL] [Abstract][Full Text] [Related]
32. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell. Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW Front Immunol; 2022; 13():1016982. PubMed ID: 36405751 [TBL] [Abstract][Full Text] [Related]
33. Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections. Lin JD; Feng N; Sen A; Balan M; Tseng HC; McElrath C; Smirnov SV; Peng J; Yasukawa LL; Durbin RK; Durbin JE; Greenberg HB; Kotenko SV PLoS Pathog; 2016 Apr; 12(4):e1005600. PubMed ID: 27128797 [TBL] [Abstract][Full Text] [Related]
34. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Okabayashi T; Kojima T; Masaki T; Yokota S; Imaizumi T; Tsutsumi H; Himi T; Fujii N; Sawada N Virus Res; 2011 Sep; 160(1-2):360-6. PubMed ID: 21816185 [TBL] [Abstract][Full Text] [Related]
35. Herpesviruses and the Type III Interferon System. Yin Y; Favoreel HW Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088 [TBL] [Abstract][Full Text] [Related]
36. Interferon lambda as a potential new therapeutic for hepatitis C. Miller DM; Klucher KM; Freeman JA; Hausman DF; Fontana D; Williams DE Ann N Y Acad Sci; 2009 Dec; 1182():80-7. PubMed ID: 20074277 [TBL] [Abstract][Full Text] [Related]
37. Shared and Distinct Functions of Type I and Type III Interferons. Lazear HM; Schoggins JW; Diamond MS Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506 [TBL] [Abstract][Full Text] [Related]